1. Home
  2. WFCF vs TENX Comparison

WFCF vs TENX Comparison

Compare WFCF & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Where Food Comes From Inc.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$13.20

Market Cap

61.5M

Sector

Technology

ML Signal

N/A

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$1.89

Market Cap

71.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
TENX
Founded
1996
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.5M
71.1M
IPO Year
2006
2001

Fundamental Metrics

Financial Performance
Metric
WFCF
TENX
Price
$13.20
$1.89
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$29.67
AVG Volume (30 Days)
6.0K
7.0M
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$20,774,416.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$127.00
N/A
Revenue Growth
16.69
N/A
52 Week Low
$9.15
$1.31
52 Week High
$22.15
$19.40

Technical Indicators

Market Signals
Indicator
WFCF
TENX
Relative Strength Index (RSI) 51.89 26.18
Support Level $11.02 $1.31
Resistance Level $14.42 $2.43
Average True Range (ATR) 1.19 0.19
MACD -0.02 0.47
Stochastic Oscillator 13.33 37.11

Price Performance

Historical Comparison
WFCF
TENX

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company conducting both on-site and desk audits to verify that claims being made about livestock, food, other high-value specialty crops and agricultural and aquaculture products are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. It also provides a wide range of professional consulting services. It generates the majority of its revenue from Verification and certification services.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: